MENU
SLNCF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Silence Therapeutics (SLNCF) Ownership - Who owns Silence Therapeutics?

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more

Profile

Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
225.29M
P/E Ratio
N/A
Total Cash
136.53M
Projected Growth
N/A
Total Debt
60K
Revenue
27.7M
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash/Share
0.96
Total Debt/Equity
N/A
Revenue/Share
0.20 USD as % of share price

Fundamentals

SLNCF
Capitalization
225M
P/E Ratio
N/A
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash
137M
Total Cash/Share
0.96
Total Debt
60K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.20%
Revenue
27.7M
ROE
N/A
Book Value
-112.74M
P/B Ratio
1.03
Cash Flow
N/A
Earnings
-0.51
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
-10.29M
Current Ratio
8.81
Current Revenue Per Employee
1224.14
Dividends Per Share - Security
N/A
EBITDA
-71.65M
Float
N/A
Float - Current
N/A
Gross Income Margin
61.97
Revenue To Assets
-33.21
Shares Held By Institutions
160
Shares Outstanding - Current
142M
Total Liabilities
298M
Total Volume MTD
N/A
Value
1
Gain YTD
-39.429
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com